Tenaya Therapeutics Inc

Research Tenaya Therapeutics Inc (TNYA) on Bullrun: market cap USD 159.47M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerTNYA
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 159.47M
• Financial periodFY2025
• Net income-USD 90.60M
• Free cash flow-USD 68.88M

Valuation Snapshot

latest market cap is USD 159.47M.

About Tenaya Therapeutics Inc

Tenaya Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. Its lead product candidate includes TN-201, a gene therapy for myosin binding protein C3-associated hypertrophic cardiomyopathy that is in Phase 1b/2 clinical trial; TN-401, a gene therapy for plakophilin 2-associated arrhythmogenic right ventricular cardiomyopathy, which is in Phase 1b/2 clinical trial;

Frequently asked questions

What is Tenaya Therapeutics Inc's market cap?

Tenaya Therapeutics Inc's market capitalization is USD 159.47M.

What does Tenaya Therapeutics Inc do?

Tenaya Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States.